Pancreatic ductal adenocarcinoma is the most common type of pancreatic cancer, accounting for 95% of all pancreatic cancers. You may be searching for information about this disease because you or a loved one is experiencing some symptoms.
In fact, pancreatic ductal adenocarcinoma is quite insidious and often shows no symptoms in the early stages. Since pancreatic adenocarcinoma constitutes ninety-five percent of malignant pancreatic tumors, early diagnosis is of great importance. As the disease progresses, symptoms such as jaundice, back pain, dark urine, and pale stools may appear. In this article, we will explain what pancreatic ductal adenocarcinoma is, its symptoms, diagnosis, and treatment processes in a clear and understandable manner.
What is Pancreatic Ductal Adenocarcinoma?
Pancreatic ductal adenocarcinoma is the most malignant type of tumor seen in the pancreas and accounts for approximately 95% of all malignant pancreatic tumors. This type of cancer starts from the cells lining the ducts (ducts) in the pancreas and progresses insidiously.
Structure and Function of the Pancreas
The pancreas is a leaf-shaped organ located in the abdominal cavity behind the stomach, approximately 15-20 cm long. This gland, resembling the end of a hockey stick, consists of three main sections: head, body, and tail. The pancreas has both endocrine (internal secretion) and exocrine (external secretion) functions, performing two important roles.
For the digestive system, the pancreas secretes enzymes such as amylase, lipase, and trypsin that help break down food. On the other hand, it has Langerhans islets that produce vital hormones like insulin and glucagon to regulate blood sugar levels. Thanks to this dual function, the pancreas plays a critical role in the body’s metabolic balance.
Cells Where Ductal Adenocarcinoma Develops
As the name suggests, pancreatic ductal adenocarcinoma begins in the cells lining the small ducts (ducts) inside the pancreas. These cells normally help transport digestive fluids produced by the pancreas to the small intestine. However, when mutations occur in these cells for various reasons, uncontrolled growth begins, leading to tumor formation.
This type of cancer originates from the exocrine cells found in the pancreas and develops in the pancreatic ducts. Approximately two-thirds of tumors are located in the head of the pancreas (the part closest to the small intestine), while the remainder is seen in the body or tail of the gland.
Difference Between Pancreatic Adenocarcinoma and Other Tumors
Two types of tumors can develop in the pancreas: exocrine tumors and neuroendocrine tumors. Pancreatic ductal adenocarcinoma falls under the exocrine tumor group and constitutes an average of 93% of pancreatic tumors.
Other periampullary tumors (such as tumors of the distal bile duct, Vater’s papilla, and duodenum) and pancreatic cystic tumors have different behaviors and treatment methods. Particularly, neuroendocrine tumors arise from hormone-producing cells and represent only 5% of all pancreatic tumors.
Pancreatic ductal adenocarcinoma is more aggressive compared to other tumors and is usually diagnosed in advanced stages. This type of cancer often goes symptomless in the early stages, but as it progresses, it can cause symptoms such as digestive issues, jaundice, back pain, and weight loss.
Therefore, pancreatic ductal adenocarcinoma is known as the most common type of pancreatic cancer that progresses insidiously, is difficult to diagnose early, and originates from the cells in the pancreatic ducts.
Symptoms of Pancreatic Ductal Adenocarcinoma
It is quite rare for pancreatic ductal adenocarcinoma to show symptoms in the early stages. However, as the tumor grows and progresses, various symptoms begin to emerge. These symptoms can vary depending on the location of the disease in your body and how advanced it is.
Painless Jaundice and Itching of the Skin
Jaundice is one of the most common and noticeable symptoms of pancreatic ductal adenocarcinoma. Especially in tumors located in the head of the pancreas, the bile duct gets blocked, resulting in yellowing of the skin and the whites of the eyes. This condition, medically termed “obstructive jaundice,” usually occurs painlessly and is often the reason patients seek medical attention. Jaundice is often accompanied by widespread and uncomfortable itching of the skin, which arises from bile acids accumulating in the blood stimulating the nerve endings in the skin.
Dark Urine and Pale Stools
Jaundice does not occur alone. The bile pigment “bilirubin” that cannot be excreted from the body accumulates in the blood and is attempted to be excreted through urine. As a result, the urine takes on a very dark color, resembling “tea or cola color.” Additionally, since the bile pigments that normally give stool its brown color cannot flow into the intestine, the stool color turns pale, resembling “clay-like” white. These two symptoms are important signs that can help detect pancreatic cancer in its early stages.
Loss of Appetite and Weight Loss
One of the frequently observed early symptoms in pancreatic cancer patients is loss of appetite and unexplained weight loss. Patients may experience significant weight loss without a clear reason. This symptom is particularly more common in cancers of the head of the pancreas. Loss of appetite and weight loss may arise from the body’s metabolic response to cancer or may occur due to the tumor affecting digestive functions.
Back Pain and Fatigue
As cancer progresses, pain that starts in the upper abdomen and radiates to the back is common. This pain usually worsens at night and can intensify when lying down. Particularly in tumors that have spread towards the back of the pancreas, the pain radiating to the back is more pronounced. Chronic fatigue and weakness are also commonly observed symptoms in pancreatic cancer patients. Especially in advanced stages of the disease, a significant feeling of fatigue arises due to disruptions in the body’s energy balance.
Digestive Issues and Diarrhea
Since the pancreas produces digestive enzymes, various digestive issues arise due to the tumor affecting this function:
- Bloating and indigestion
- Nausea and vomiting
- Fatty, foul-smelling stools (steatorrhea)
- Severe and persistent diarrhea
These symptoms arise from the inability to properly digest food and may contribute to weight loss. Additionally, pancreatic cancer patients may experience changes in bowel movements, leading to diarrhea or constipation.
When you notice all these symptoms, especially when very typical symptoms such as painless jaundice, dark urine, and pale stools are seen together, it is vital to consult a doctor without delay.
Diagnosis Process and Methods Used
Accurate diagnosis of pancreatic ductal adenocarcinoma is vital for appropriate treatment planning. When symptoms appear, it is usually in an advanced stage, so various imaging techniques and tests are used for a definitive diagnosis.
Computed Tomography (CT)
Computed tomography is the primary examination method for diagnosing pancreatic cancer. A contrast-enhanced CT scan shows the size, location, and relationship of the tumor with surrounding tissues in detail. It also provides important information for evaluating the operability of the tumor, vascular involvement, and lymph node spread. The accuracy rate of CT scans is 100% for lesions larger than 15 mm. However, for smaller tumors, this rate can drop to 67%.
Magnetic Resonance Imaging (MRI)
MRI provides more detailed imaging of soft tissues and is particularly more sensitive than CT in evaluating possible liver metastases. It can be used as an alternative for tumors not detected by CT and is quite successful in showing liver metastases. The accuracy rate of MRI is approximately 83%, and this rate is gradually increasing with technological advancements.
Endoscopic Ultrasound (EUS)
Endoscopic ultrasound is the method with the highest accuracy rate for diagnosing pancreatic cancer (93-100%). EUS provides imaging from a very close angle to the pancreas using a high-frequency ultrasound probe placed at the end of the endoscope. Thus, even lesions smaller than 1 cm, which cannot be detected by standard imaging methods, can be easily identified.
The greatest advantage of EUS is that biopsy can be performed in the same session. Fine needle aspiration biopsies (FNAB) performed under EUS guidance increase diagnostic sensitivity to 85-95% and specificity to 100%. It has superiority over other diagnostic methods, especially in evaluating small tumors.
Biopsy and Laboratory Tests
For a definitive diagnosis, a sample must be taken from the suspicious tissue (biopsy). The most commonly used biopsy method in pancreatic cancer is fine needle aspiration performed under EUS guidance. In this procedure, while the mass is clearly visualized with EUS, safe cell samples are taken from the mass using a fine needle advanced through the endoscope.
Laboratory tests look for tumor markers such as CA 19-9 and CEA. Elevated levels of these markers may indicate pancreatic cancer. Additionally, in cases of bile duct obstruction, abnormal results may also be seen in bilirubin and liver function tests.
Staging: From 0 to 4
Staging of pancreatic cancer is used to understand how advanced the tumor is and to create an appropriate treatment plan. Staging is based on the TNM system (Tumor, Lymph Nodes, Metastasis).
- Stage 0: Cancer is confined to the cells in the pancreatic ducts and has not spread to surrounding tissues (carcinoma in situ).
- Stage I: The tumor is confined to the pancreas, with no spread to lymph nodes or distant organs.
- Stage II: The tumor has spread to nearby tissues outside the pancreas or to lymph nodes, but there is no distant metastasis.
- Stage III: Cancer has spread to the major blood vessels or nerves surrounding the pancreas.
- Stage IV: Cancer has spread to distant organs such as the liver and lungs (metastasis).
For accurate staging, advanced imaging methods such as CT, MRI, EUS, and sometimes PET-CT are used together.
Treatment Options and Application Criteria
The treatment of pancreatic ductal adenocarcinoma is determined based on the stage of the disease and the overall health status of the patient. The correct treatment approach is crucial for extending the patient’s lifespan and improving their quality of life.
Surgical Intervention (Whipple Procedure)
The Whipple procedure is the most effective treatment method for pancreatic cancer. In this procedure, the head of the pancreas, duodenum, gallbladder, and part of the bile duct are removed. The remaining organs are then reconnected to preserve the function of the digestive system. This complex surgery requires high expertise, so it is important to perform it in specialized centers. According to statistics, only 15-20% of pancreatic cancer patients are in a condition suitable for surgical treatment at the time of diagnosis.
Chemotherapy and Radiotherapy
Chemotherapy is a drug treatment used to destroy cancer cells or stop their growth. Protocols such as gemcitabine and FOLFIRINOX are commonly used. It can be applied to eliminate microscopic cancer cells remaining after surgery. Radiotherapy works by sending high-energy beams to cancer cells and often yields more effective results when used in conjunction with chemotherapy.
Immunotherapy and Targeted Treatments
In recent years, new developments have emerged in the treatment of pancreatic cancer. Especially in patients with KRAS G12D mutation (40-45% of cases), new targeted therapies have been developed. New drugs such as INCB161734 and seti-degrasib show promising results both alone and in combination with chemotherapy. Immunotherapy works by strengthening the body’s immune system against cancer cells and can be evaluated particularly in patients with certain genetic features (such as MSI-H).
Criteria for Treatment Suitability
When determining treatment options, the following factors are considered:
- Size, location, and spread of the tumor
- Overall health status and age of the patient
- Other accompanying diseases
Criteria for surgical suitability include the degree of involvement of the tumor with major vessels, whether there is spread to distant organs, and whether the patient is in a condition to undergo surgery. In patients who are not suitable for surgery, chemotherapy, radiotherapy, or palliative treatments are preferred.
Post-Treatment Follow-Up Process
Regular follow-up after treatment is vital. Patients are called for check-ups every 3-4 months in the first year and every 6 months in subsequent years. During the follow-up process, blood tests (such as tumor markers like CA 19-9) and imaging methods (CT, MRI) are used. Additionally, patients who have undergone the Whipple procedure may need to change their dietary habits. Initially, they start with liquid foods and gradually transition to soft and easily digestible foods. Pancreatic enzyme support and insulin treatment, if necessary, are also part of the process.
Risk Factors and Life Expectancy
The risk of developing pancreatic ductal adenocarcinoma is influenced by various factors. Understanding the risk factors and life expectancy is crucial for early diagnosis and appropriate treatment planning.
Genetic Predisposition and Family History
Approximately 10% of pancreatic cancers are hereditary. Individuals with a family history of pancreatic cancer have a higher risk of developing this disease. The risk increases 3-5 times in first-degree relatives (mother, father, siblings) with a history of pancreatic cancer. More strikingly, individuals with three or more family members with pancreatic cancer may have a risk increase of up to 30 times. Genetic mutations such as BRCA1, BRCA2, and PALB2 are also factors that increase the risk of pancreatic cancer.
Smoking, Alcohol, and Obesity
Smoking is the most significant preventable cause of pancreatic cancer. Studies show that smokers are 2-3 times more likely to develop pancreatic cancer compared to non-smokers. Additionally, smoking accounts for approximately 30% of pancreatic cancer cases. Excessive alcohol consumption also increases the risk by 1.5-2 times. Furthermore, obesity is an important risk factor. Every 5-unit increase in body mass index raises the risk of pancreatic cancer by 10%.
Diabetes and Chronic Pancreatitis
Diabetes doubles the risk of developing pancreatic cancer. Interestingly, diabetes may sometimes appear as the first symptom of pancreatic cancer. Especially in individuals over 50 years old without a family history of diabetes, the sudden onset of diabetes may indicate undiagnosed pancreatic cancer. Patients with chronic pancreatitis are also at significantly higher risk for pancreatic cancer. In these patients, the risk is 10-15 times higher compared to healthy individuals.
Organs Where Metastasis Occurs
Pancreatic cancer most frequently metastasizes to the liver. Studies have shown that the rate of liver metastasis can reach up to 83.6%. The second most common site is lung metastases (26%). Additionally, the peritoneal area (abdominal lining) and distant lymph nodes are also common sites of pancreatic cancer spread. This pattern of spread directly affects the stage of the disease and the treatment plan.
Factors Affecting Life Expectancy
Life expectancy in pancreatic ductal adenocarcinoma depends on many factors. The most important is the stage of the disease. In localized (confined to the pancreas only) cancer, the 5-year survival rate can be as high as 44%. In cases of regional spread, this rate drops to 15%, and in the presence of distant metastasis, it falls to 3%. The proportion of patients who may be eligible for surgical treatment is only around 10-15%. The overall health status of the patient, the characteristics of the tumor, and the response to treatment are also other factors that affect life expectancy. The 5-year survival rate for metastatic pancreatic cancer is approximately 3%, and treatment is usually performed with chemotherapy.
In Summary: Pancreatic Ductal Adenocarcinoma
As seen, pancreatic ductal adenocarcinoma is a disease that progresses insidiously and is often diagnosed late. It is vital to notice symptoms such as painless jaundice, back pain, and weight loss. If you experience any of these symptoms, you should consult a doctor without delay.
Knowing the risk factors and having regular health check-ups can increase the success of early diagnosis. Lifestyle changes such as reducing smoking and alcohol consumption and maintaining a healthy weight can help lower the risk of the disease. Additionally, individuals with a family history of pancreatic cancer are advised to be more vigilant.
However, thanks to advancements in the medical field, diagnosis and treatment options are continuously improving. Surgical intervention, chemotherapy, and newly developed targeted drugs are increasing patients’ life expectancy and quality of life. Therefore, early diagnosis, the correct treatment approach, and regular follow-up are key to achieving positive outcomes in pancreatic cancer.
In conclusion, being informed about pancreatic cancer and raising awareness is of great importance. This way, you can notice symptoms early, avoid risk factors, and seek appropriate medical help when needed. Remember that, as with any disease, early diagnosis can save lives in pancreatic cancer.
Frequently Asked Questions
We have compiled frequently asked questions about pancreatic ductal adenocarcinoma for you. In this section, we answer the most common questions related to the disease.
Where does the pain occur in pancreatic cancer? Pain is usually felt in the upper abdomen and radiates to the back.
Can pancreatic cancer occur at a young age? Although it is mostly seen in older ages, it can also develop in younger individuals with genetic predisposition.
Which blood test indicates pancreatic cancer? There is no single blood test for a definitive diagnosis, but tumor markers such as CA 19-9 and CEA can assist in diagnosis.
Can pancreatic cancer be seen on ultrasound? Yes, ultrasound can help detect cancer by creating images of the pancreas. Two types of ultrasound are used: abdominal ultrasound and endoscopic ultrasound.
Can pancreatic cancer be cured with surgery? If diagnosed in the early stage, the tumor can be completely removed through surgery, leading to recovery. After the Whipple procedure, the patient can return to normal life within approximately 6 months.
Where does pancreatic cancer metastasize first? The cancer can primarily spread within the abdomen and to the liver. It can later spread to the lungs and bones.
Pancreatic ductal adenocarcinoma accounts for 95% of pancreatic cancer. Early diagnosis is difficult, with symptoms including jaundice, back pain, and weight loss. Explore treatment options.
